Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients
Overall design
The aim of this study was to measure gut microbiota alterations and aberrant metabolism in diarrhoea-predominant irritable bowel syndrome (IBS-D) patients with depressive symptoms. Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) harvested urinary metabolomic data from 70 IBS-D (IBS-D group) and 42 healthy control (control group) samples. The mean score of the Hamilton Depression Scale was 13.23 for the IBS-D group.
Depressive symptom; Depressive symptom with comorbidity; Depressive symptom with comorbidity;
Criteria for depression
Not reported
Sample size
112
Tissue
Peripheral; Urine; Urine;
Platform
MS-based; LC-MS: Ultimate 3000 ultra-high performance liquid chromatography system (Dionex, Sunnyvale, CA, United States) united with Q Exactiv Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, Waltham, MA, United States);
Liu T, Gu X, Li LX, et al. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients. BMC Microbiol. 2020 Jun 17;20(1):168.